Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for co…
This bill (SEEK HELP Act) creates limited federal protections related to opioid overdoses. It (1) provides civil immunity for people who in good faith administer an opioid overdose reversal drug (e.g., naloxone) to someone who appears to be overdosing, except for willful or grossly negligent conduct; (2) protects a ‘‘covered individual’’ who in good faith seeks timely medical assistance for an overdose (for themselves or another) from prosecution, civil asset forfeiture, or revocation of supervised release for possession of a controlled substance when the sole basis for discovering the possession is the act of seeking assistance, with exceptions for outstanding warrants and searches incident to lawful processes; (3) directs HHS (with DEA consultation) to run a public awareness campaign and authorizes JAG and certain Public Health Service block grant funds to be used for training and outreach about Good Samaritan protections; and (4) requires a GAO report within 2 years evaluating how Good Samaritan overdose laws are implemented and their effects.
Scope of legal protections: liberals emphasize life-saving and broader harm-reduction gains; conservatives worry the protections weaken law enforcement and deterrence.
Relative to its intended legislative type, this bill is a well-specified substantive policy change establishing immunity provisions for overdose-related assistance, accompanied by administrative adjustments for outreach and a detailed GAO evaluation requirement.
This bill (SEEK HELP Act) creates limited federal protections related to opioid overdoses.
It (1) provides civil immunity for people who in good faith administer an opioid overdose reversal drug (e.g., naloxone) to someone who appears to be overdosing, except for willful or grossly negligent conduct; (2) protects a ‘‘covered individual’’ who in good faith seeks timely medical assistance for an overdose (for themselves or another) from prosecution, civil asset forfeiture, or revocation of supervised release for possession of a controlled substance when the sole basis for discovering the possession is the act of seeking assistance, with exceptions for outstanding warrants and searches incident to lawful processes; (3) directs HHS (with DEA consultation) to run a public awareness campaign and authorizes JAG and certain Public Health Service block grant funds to be used for training and outreach about Good Samaritan protections; and (4) requires a GAO report within 2 years evaluating how Good Samaritan overdose laws are implemented and their effects.
Many specifics about scope, data sharing, and state-federal interaction are set out in the bill text.
On content alone, the bill is a narrowly tailored, low-cost public-health/criminal-justice tweak that mirrors existing and broadly supported state Good Samaritan approaches. Its limited fiscal impact, clear exceptions, use of existing grant authorities, and an evaluation requirement make it administratively straightforward and politically palatable in many settings — increasing its chances of enactment. The principal barriers are typical Senate procedural hurdles and potential pushback from actors concerned about limiting prosecutorial tools.
Relative to its intended legislative type, this bill is a well-specified substantive policy change establishing immunity provisions for overdose-related assistance, accompanied by administrative adjustments for outreach and a detailed GAO evaluation requirement.
Scope of legal protections: liberals emphasize life-saving and broader harm-reduction gains; conservatives worry the protections weaken law enforcement and deterrence.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope of legal protections: liberals emphasize life-saving and broader harm-reduction gains; conservatives worry the protections weaken law enforcement and deterrence.
A mainstream liberal would likely view the bill positively as a targeted, evidence-based harm reduction measure that can save lives by reducing fear of calling for help during overdoses.
They would note the civil immunity for bystanders who administer naloxone and the criminal/forfeiture protections for those who seek help as pragmatic steps to reduce overdose fatalities.
They would welcome the funding flexibility for public outreach and the GAO evaluation to build an evidence base.
A pragmatic centrist would likely view the bill as a narrowly tailored, commonsense policy aimed at saving lives with built-in evaluation.
They would appreciate the limited scope (good-faith administration of reversal drugs and protections tied only to possession disclosures from seeking help) and the GAO study to measure effectiveness.
They would also watch for interstate legal interactions, potential enforcement ambiguities, and the fiscal and administrative burden of outreach programs.
A mainstream conservative would likely be skeptical of parts of the bill that reduce criminal consequences or constrain forfeiture when evidence is uncovered because someone sought medical help.
They may nevertheless find the limited civil immunity for naloxone administration acceptable as a narrow Good Samaritan protection.
Key concerns would be that the bill could create perverse incentives, weaken deterrence, or impede law enforcement and asset forfeiture tools.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a narrowly tailored, low-cost public-health/criminal-justice tweak that mirrors existing and broadly supported state Good Samaritan approaches. Its limited fiscal impact, clear exceptions, use of existing grant authorities, and an evaluation requirement make it administratively straightforward and politically palatable in many settings — increasing its chances of enactment. The principal barriers are typical Senate procedural hurdles and potential pushback from actors concerned about limiting prosecutorial tools.
The bill has not accumulated any surfaced votes yet.
Scope of legal protections: liberals emphasize life-saving and broader harm-reduction gains; conservatives worry the protections weaken law…
On content alone, the bill is a narrowly tailored, low-cost public-health/criminal-justice tweak that mirrors existing and broadly supporte…
Relative to its intended legislative type, this bill is a well-specified substantive policy change establishing immunity provisions for overdose-related assistance, accompanied by administrative adjustments for outreach…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.